577 related articles for article (PubMed ID: 12325041)
1. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
Berridge CW; Stalnaker TA
Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
[TBL] [Abstract][Full Text] [Related]
2. Difference in magnitude of psychostimulant-induced extracellular norepinephrine in the ventral tegmental area contributes to discrepant prefrontal dopamine outflow.
Pan WH; Hsieh MC; Wu HH; Lin SK
Addict Biol; 2007 Mar; 12(1):51-8. PubMed ID: 17407497
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
[TBL] [Abstract][Full Text] [Related]
4. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
5. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area.
Vittoz NM; Berridge CW
Neuropsychopharmacology; 2006 Feb; 31(2):384-95. PubMed ID: 15988471
[TBL] [Abstract][Full Text] [Related]
6. Influence of chronic exercise on the amphetamine-induced dopamine release and neurodegeneration in the striatum of the rat.
Marques E; Vasconcelos F; Rolo MR; Pereira FC; Silva AP; Macedo TR; Ribeiro CF
Ann N Y Acad Sci; 2008 Oct; 1139():222-31. PubMed ID: 18991868
[TBL] [Abstract][Full Text] [Related]
7. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment.
Florin SM; Kuczenski R; Segal DS
Brain Res; 1994 Aug; 654(1):53-62. PubMed ID: 7982098
[TBL] [Abstract][Full Text] [Related]
8. Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats.
Gruner JA; Mathiasen JR; Flood DG; Gasior M
J Pharmacol Exp Ther; 2011 May; 337(2):380-90. PubMed ID: 21300706
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.
Bongiovanni R; Newbould E; Jaskiw GE
Brain Res; 2008 Jan; 1190():39-48. PubMed ID: 18082673
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
Pan WH; Yang SY; Lin SK
Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
[TBL] [Abstract][Full Text] [Related]
11. Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
Pan WH; Sung JC; Fuh SM
J Pharmacol Exp Ther; 1996 Aug; 278(2):725-31. PubMed ID: 8768724
[TBL] [Abstract][Full Text] [Related]
12. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Moroz IA; Peciña S; Schallert T; Stewart J
Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
[TBL] [Abstract][Full Text] [Related]
14. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
Jordan S; Kramer GL; Zukas PK; Moeller M; Petty F
Synapse; 1994 Dec; 18(4):294-7. PubMed ID: 7886621
[TBL] [Abstract][Full Text] [Related]
15. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine.
Grant A; Hoops D; Labelle-Dumais C; Prévost M; Rajabi H; Kolb B; Stewart J; Arvanitogiannis A; Flores C
Eur J Neurosci; 2007 Dec; 26(11):3215-28. PubMed ID: 18005074
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis.
Alexander M; Rothman RB; Baumann MH; Endres CJ; Brasić JR; Wong DF
Synapse; 2005 May; 56(2):94-9. PubMed ID: 15729739
[TBL] [Abstract][Full Text] [Related]
17. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
Devoto P; Flore G; Pira L; Diana M; Gessa GL
Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
[TBL] [Abstract][Full Text] [Related]
18. Neural substrates of psychostimulant-induced arousal.
Berridge CW
Neuropsychopharmacology; 2006 Nov; 31(11):2332-40. PubMed ID: 16855535
[TBL] [Abstract][Full Text] [Related]
19. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
[TBL] [Abstract][Full Text] [Related]
20. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle.
Levi MS; Divine B; Hanig JP; Doerge DR; Vanlandingham MM; George NI; Twaddle NC; Bowyer JF
Neurotoxicol Teratol; 2012 Mar; 34(2):253-62. PubMed ID: 22289608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
